LAWSON MARK enters HELUS PHARMA INC. with 160.03K shares across direct and indirect positions
This filing by LAWSON MARK establishes the baseline for all future Form 4 insider transaction reports at HELUS PHARMA INC..
Direct Indirect
Filed: 10/23/2026ACC: 0000912282-26-001380
160.03K
Baseline shares
2% direct
3.03K
Direct ownership
1 position
0.00
Derivative underlying
0 instruments
2
Security positions
157K indirect
Non-Derivative Holdings2
Common Shares
IndirectShares owned157K
Common Shares
DirectShares owned3.03K
Total
3.03K direct·157K indirect160.03K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Shares | 157K | Indirect |
| Common Shares | 3.03K | Direct |
| Total | 160.03K | 3.03K direct·157K indirect |
Derivative Holdings0
No derivative holdings reported